Loading insider details...
Latest Form 4 (Jun 29, 2026): Grant/Award of 40,000 BDTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 40,000 | n/a |
| May 27, 2026 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 114,200 | n/a |
| Jun 12, 2025 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 30,550 | n/a |
| Dec 16, 2024 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 4,500 | $11.3K |
| Sep 20, 2024 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 2,354 | $11.3K |
| Jun 21, 2024 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 2,011 | $10.0K |
| Jun 6, 2024 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 30,550 | n/a |
| Apr 12, 2024 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 61,100 | n/a |